Literature DB >> 17057808

Retinopathy of prematurity: involution, factors predisposing to retinal detachment, and expected utility of preemptive surgical reintervention.

David K Coats1.   

Abstract

PURPOSE: To characterize involution of retinopathy of prematurity (ROP) following treatment at threshold, to identify findings during involution that portend development of retinal detachment, and to assess the potential utility of preemptive vitrectomy for eyes with high-risk features.
METHODS: The probability of ROP involution and of retinal detachment evolution over time was analyzed in 262 treated eyes of 138 infants in a retrospective observational non-case controlled series. Expected utility of preemptive reintervention in eyes with high-risk features was evaluated using decision analysis. Modifications were devised to enhance classification of advanced ROP.
RESULTS: ROP fully involuted in approximately 80% of eyes within 28 days of treatment. Vitreous organization meeting the study's clinically important definition was associated with a 31-fold (5.37 to 183.63; P < .0001) and a 13-fold (2.97 to 58.59; P < .0001) increase in the odds for retinal detachment for right and left eyes, respectively. Vitreous hemorrhage defined as clinically important was associated with a 38-fold (2.69 to 551.19; P = .007) and a 15-fold (1.65 to 144.12; P = .02) increase in the odds for retinal detachment for right and left eyes, respectively. As modeled, an expected utility of 0.85 was calculated for preemptive vitrectomy compared with 0.79 for deferred vitrectomy for eyes with clinically important vitreous organization.
CONCLUSIONS: Acute-phase ROP involuted quickly in most eyes. Vitreous organization and vitreous hemorrhage were predictive of eyes that developed a retinal detachment. Decision analysis suggests that preemptive vitrectomy for eyes with vitreous organization meeting specific criteria is not likely to be worse than deferred vitrectomy, and it could be advantageous in some scenarios.

Entities:  

Mesh:

Year:  2005        PMID: 17057808      PMCID: PMC1447579     

Source DB:  PubMed          Journal:  Trans Am Ophthalmol Soc        ISSN: 0065-9533


  125 in total

1.  Lens clarity after lens-sparing vitrectomy in a pediatric population.

Authors:  P J Ferrone; C Harrison; M T Trese
Journal:  Ophthalmology       Date:  1997-02       Impact factor: 12.079

2.  An international classification of retinopathy of prematurity. II. The classification of retinal detachment. The International Committee for the Classification of the Late Stages of Retinopathy of Prematurity.

Authors: 
Journal:  Arch Ophthalmol       Date:  1987-07

3.  Natural history of retinopathy of prematurity.

Authors:  W E Schulenburg; A Prendiville; R Ohri
Journal:  Br J Ophthalmol       Date:  1987-11       Impact factor: 4.638

4.  In situ actin distribution in excised retrolental membranes in retinopathy of prematurity.

Authors:  H K Soong; A W Eller; T Hirose; L Hanninen; K R Kenyon
Journal:  Arch Ophthalmol       Date:  1985-10

5.  Acquired cataracts after argon laser photocoagulation for retinopathy of prematurity.

Authors:  J W O'Neil; A K Hutchinson; R A Saunders; M E Wilson
Journal:  J AAPOS       Date:  1998-02       Impact factor: 1.220

6.  Does candidemia predict threshold retinopathy of prematurity in extremely low birth weight (</=1000 g) neonates?

Authors:  M G Karlowicz; P J Giannone; J Pestian; A L Morrow; J Shults
Journal:  Pediatrics       Date:  2000-05       Impact factor: 7.124

7.  Involution of retinopathy of prematurity. Cryotherapy for Retinopathy of Prematurity Cooperative Group.

Authors:  M X Repka; E A Palmer; B Tung
Journal:  Arch Ophthalmol       Date:  2000-05

8.  Childhood blindness.

Authors:  P G Steinkuller; L Du; C Gilbert; A Foster; M L Collins; D K Coats
Journal:  J AAPOS       Date:  1999-02       Impact factor: 1.220

9.  Vitreous hemorrhage nontoxic to retina as a stimulator of glial and fibrous proliferation.

Authors:  M Ehrenberg; R J Thresher; R Machemer
Journal:  Am J Ophthalmol       Date:  1984-05       Impact factor: 5.258

10.  Blindness in infants and young children.

Authors:  E M Hatfield
Journal:  Sight Sav Rev       Date:  1972
View more
  11 in total

1.  Intravitreal bevacizumab in retinopathy of prematurity: an interventional case series.

Authors:  Ramak Roohipoor; Hamed Ghasemi; Fariba Ghassemi; Reza Karkhaneh; Mohammad Riazi-Esfahani; Mehdi Nili-Ahmadabadi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-04-15       Impact factor: 3.117

2.  No relationship between mode of delivery and neonatal mortality and neurodevelopment in very low birth weight infants aged two years.

Authors:  Jia-Jun Zhu; Ying-Ying Bao; Guo-Lian Zhang; Li-Xin Ma; Ming-Yuan Wu
Journal:  World J Pediatr       Date:  2014-08-15       Impact factor: 2.764

Review 3.  Advances in understanding and management of retinopathy of prematurity.

Authors:  Mary Elizabeth Hartnett
Journal:  Surv Ophthalmol       Date:  2016-12-22       Impact factor: 6.048

Review 4.  Vascular endothelial growth factor antagonist therapy for retinopathy of prematurity.

Authors:  M Elizabeth Hartnett
Journal:  Clin Perinatol       Date:  2014-09-23       Impact factor: 3.430

5.  Intravitreal bevacizumab in combination with laser therapy for the treatment of severe retinopathy of prematurity (ROP) associated with vitreous or retinal hemorrhage.

Authors:  Hossein Nazari; Mehdi Modarres; Mohammad Mehdi Parvaresh; Khalil Ghasemi Falavarjani
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-06-27       Impact factor: 3.117

Review 6.  Studies on the pathogenesis of avascular retina and neovascularization into the vitreous in peripheral severe retinopathy of prematurity (an american ophthalmological society thesis).

Authors:  Mary Elizabeth Hartnett
Journal:  Trans Am Ophthalmol Soc       Date:  2010-12

7.  Insights into advanced retinopathy of prematurity using handheld spectral domain optical coherence tomography imaging.

Authors:  Sai H Chavala; Sina Farsiu; Ramiro Maldonado; David K Wallace; Sharon F Freedman; Cynthia A Toth
Journal:  Ophthalmology       Date:  2009-09-18       Impact factor: 12.079

Review 8.  Natural product inhibitors of ocular angiogenesis.

Authors:  Rania S Sulaiman; Halesha D Basavarajappa; Timothy W Corson
Journal:  Exp Eye Res       Date:  2014-10-07       Impact factor: 3.467

9.  A review of treatment for retinopathy of prematurity.

Authors:  Eric D Hansen; M Elizabeth Hartnett
Journal:  Expert Rev Ophthalmol       Date:  2019-03-29

10.  The genetic control of avascular area in mouse oxygen-induced retinopathy.

Authors:  Bliss E O'Bryhim; Jeff Radel; Stuart J Macdonald; R C Andrew Symons
Journal:  Mol Vis       Date:  2012-02-08       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.